Overall survival was numerically longer after surgery than after SBRT, but the difference was not statistically significant, and SBRT may be a reasonable option for patients who cannot undergo surgery.
Abstract
Simple Summary Colorectal cancer often spreads to the liver, and the only potentially curative treatments are surgery and a precise form of radiotherapy called stereotactic body radiotherapy (SBRT). It was not clear whether one treatment offers a survival advantage over the other. We reviewed the records of 40 patients treated with either surgery or SBRT for liver metastases from colorectal cancer at a single medical center. Overall survival was numerically longer after surgery than after SBRT, but the difference was not statistically significant. Patients whose tumors involved more than one part of the liver had a higher risk of disease progression, and tumors located in the left part of the liver were linked to more progression regardless of treatment. These findings support personalizing treatment choice for each patient and suggest SBRT may be a reasonable option for patients who cannot undergo surgery.
Simple Summary Pancreatic cancer (PC) is the eleventh most common cancer in the world and is the seventh leading cause of global cancer deaths. The exact cause of PC is not well defined. About 5–10% of patients are associated with hereditary pancreatic cancer syndrome. The most common histological type is pancreatic du...
K. Joseph, Ben Burke, Amr Heikal et al.· Current Oncology· 0 citations
Aim.
Using data from research studies, to analyze the efficacy and safety of performing simultaneous surgeries for synchronous colorectal cancer metastases to the liver, and to identify risk factors for postoperative complications. Since the early 2000s, hepatectomy has been the standard procedure for treating metas...
I. R. Skopina, A. Svechkova, A. A. Trushin et al.· Annaly khirurgicheskoy gepat...· 0 citations
Purpose Total mesorectal excision (TME) is the standard treatment for early rectal cancer, but radiation therapy (RT) with or without chemotherapy may be considered as an alternative organ-preserving option. This study evaluated the oncologic outcomes, patterns of failure, salvage treatment efficacy, and TME–free survi...
Seo Jin Lee, H. K. Byun, Jee-Suk Chang et al.· Radiation Oncology Journal· 0 citations
Rectal cancer represents one of the most difficult oncological challenges due to its high risk of recurrence and multiple treatment complications. Recent decades have witnessed significant advances in the treatment of this malignancy, mainly due to the introduction of Total Mesorectal Excision and the use of perioperat...
Z. Lorenc, Jakub Wantulok, M. Święch et al.· Nowa Medycyna· 0 citations
Background/Aim: Patients with stage IV colorectal cancer and multiple distant metastases are generally treated with systemic chemotherapy. However, treatment options may be limited in elderly patients with severe comorbidities or poor performance status. We report a case of long-term disease-free survival after repeate...
Taishi Yamane, T. Masuda, Yasunori Nagayama et al.· Anticancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.